Teflex Products

View by:
Teflex Products

Showing all 5 results

  • Role Simulations
    View Details This product has multiple variants. The options may be chosen on the product page
    Business and Commercial Role-Play:

    DirtyStuff I

    Lawrence Susskind
    Five-person, multi-issue facilitated negotiation among industry, environmental, labor, and government representatives to develop single-text regulation of toxic industrial by-product
  • Role Simulations
    View Details This product has multiple variants. The options may be chosen on the product page
    Business and Commercial Role-Play:

    DirtyStuff II

    Jeffrey Litwak and Lawrence Susskind
    Six-person, multi-issue facilitated negotiation among industry, environmental, consumer/community, labor, and government representatives to develop single-text regulation of toxic industrial by-product
  • Role Simulations
    View Details This product has multiple variants. The options may be chosen on the product page
    Public Relations Role-Play:

    First City Bank and the PressDeveloping a Public Relations Strategy

    Jeffrey Litwak and Lawrence Susskind
    Six-party negotiation among lending institution representatives, community leaders, a contractors' association, and the mayor's office to develop a public relations strategy and solutions to a foreclosure crisis caused by a widespread mortgage scam
  • Video and Audio
    View Details This product has multiple variants. The options may be chosen on the product page

    Negotiation Pedagogy Video Series, Part II

    Lawrence Susskind and Melissa Manwaring

    An unscripted video showing an experienced negotiation professor teaching an executive education session through the running and debriefing of the Teflex Products role simulation, interspersed with instructor commentary
  • Role Simulations
    View Details This product has multiple variants. The options may be chosen on the product page
    Healthcare Role-Play:

    Teflex Products

    Lawrence Susskind and James Lawrence
    Five-party, multi-issue negotiation among representatives of a pharmaceutical company, a medical drug manufacturer, and three consumer organizations over the delayed release of a new drug